15 BACKGROUND: The use of robotic trainers has increased with the aim of improving 16 gait function in patients with limitations. Nevertheless, there is an absence of studies 17 that deeply describe detailed guidelines of how to correctly implement robot-based 18 treatments for gait rehabilitation. This contribution proposes an accurate robot-based 19 training program for gait rehabilitation of pediatric population with Cerebral Palsy (CP). 20 METHODS: The program is focused on the achievement of some specifications defined 21 by the International Classification of Functioning, Disability and Health framework, 22 Children and Youth version (ICF-CY). It is framed on 16 non-consecutive sessions 23 where motor control, strength and power exercises of lower limbs are performed in 24 parallel with a postural control strategy. A clinical evaluation with four pediatric 25 patients with CP using the CPWalker robotic platform is presented. 26 RESULTS: The preliminary evaluation with patients with CP shows improvements in 27 several aspects as strength (74.03±40.20%), mean velocity (21.46±33.79%), step length 28 (17.95±20.45%) or gait performance (e.g. 18.88±14.31% in Gross Motor Function 29 Measure-88 items, E and D dimensions). 30 CONCLUSIONS: The improvements achieved in the short term show the importance of 31 working strength and power functions meanwhile over-ground training with postural 32 control. This research could serve as preliminary support for future clinical 33 implementations in any robotic device. 34 TRIAL REGISTRATION: The study was carried out with the number R-0032/12 from 35
Introduction
The use of robotic trainers for neurorehabilitation applications has increased in the last 48 decades, both in adulthood and childhood, and in several motor diseases [3] [4] [5] . based therapies have been developed and improved beyond reducing the clinician's 50 effort. Currently, a new generation of robotic devices [6-8] provides means for 51 encouraging the patients to an active participation in exercises, which are now more task 52 specific. Both the implemented novel control strategies and the modularity of new 53 exoskeletons and gait trainers offer promising possibilities to enhance the rehabilitation 54 outcomes by adapting the treatment to the patient's needs [9, 10] . Nevertheless, so far 55 there is not enough evidence to ensure that classic robot-based rehabilitation provides 56 better treatment outcomes by itself than conventional physical strategies in childhood 57 [11] . New approaches are needed in order to improve the rehabilitation, making the 58 robotic therapy a key feature of the change. 59
One of the main drawbacks for the everyday use of these technologies into the 60 rehabilitation practice, apart from the price of these devices, is the absence of studies 61 that describe a detailed robotic training program for gait rehabilitation. The wide variety 62 of changes that could be applied to the parameters of robotic training therapies, makes 63 unclear how to specify rehabilitation settings with the aim of providing a suitable 64 solution for a large population size. Additionally, most of current studies are only 65 focused on lower limbs strategies. However, the upper body (head and trunk movement) 66 also influences gait function through walking balance [12] , so a proper program should 67 not ignore these features. 68
This manuscript presents a detailed robot-based therapy proposal for the rehabilitation 69 of gait function in children with CP, which is based on the achievement of some 70 specifications defined by the International Classification of Functioning, Disability and 71
Health framework, Children and Youth version (ICF-CY) [13] . It contributes with better 72 answers on how to implement robotic rehabilitation following defined guidance, 73 establishing the baseline settings and subsequently tailoring the therapy to each patient. 74
The proposed robotic rehabilitation therapy works around a key factor: the 75 implementation of strength and power exercises at the same time than over-ground 76 walking guidance, performing in parallel an active head-trunk control therapy. As a 77 result, the robot-based program recreates a situation as similar as possible to a real gait 78 scenario, and encourages the patients to control different movements associated with 79 gait: not only individual movements of lower limb joints but also the synergy between 80 them while maintaining a proper posture of upper body. We hypothesize that these 81 essential components, performed following an appropriate progression of the variables, 82 will boost the rehabilitation of our patients. 83
Eventually, the robot-based therapy proposed in this manuscript is evaluated in four 84 patients with CP in order to provide preliminary results of its application. Although the 85 proposed robot-based treatment could be implemented in any robotic device adapted for 86 that, in this study authors selected the CPWalker training platform [7] as one scenario to 87 test the effectiveness of the approach. This device is a novel robotic prototype with 88 partial body weight support (PBWS) for over-ground rehabilitation of children with CP. 89 It provides means for adapting the therapy to the user's necessities through different 90 levels of assistance in multi-joint over-ground training. Other gait trainers, such as 91 Lokomat [14] or LOPES [6], could have been also used to evaluate this training 92 method, since they are also able to tailor each therapy session to the patient's needs. 93
Materials and Methods

94
Rehabilitation device 95 The CPWalker rehabilitation platform [7] is a robotic device composed by an 96 exoskeleton linked to a walker that provides support and balance to the child during 97 over-ground training ( Figure 1 ). The device is able to implement users' PBWS and 98 allows the adaptation of exercises to the patient's capabilities by means of individual 99 controllers for each joint, which increases the modularity of the system [7] . Each joint 100 of the CPWalker exoskeleton can operate in a wide range of modes (see Position control mode: in this mode, the robot imposes a prescribed gait 107 pattern to the user's lower limbs. The aim is that the patient learns the 108 walking motion sequence correctly. 109
ii)
Impedance control modes: these modes take into account the patients' 110 collaboration. Thereby, the prescribed gait pattern should be achieved by the 111 sum of robotic assistance and patient's cooperation. Three different modes of 112 impedance may be executed in CPWalker (high, medium and low), which 113 tolerate variable deviations from the programmed gait trajectories, enhancing 114 the patients' participation and taking advantage of their residual movements 115 through assist as needed strategies (AAN). 116
iii)
Zero-force control mode: in this mode, the trajectory reference is not given, 117 and the patient is who entirely moves the legs with a minimal resistance of 118 the exoskeleton. It is used with patients with enough motor control (acquired 119 with the previous modes) but poor balance, so the CPWalker provides 120 stability and PBWS while the patient implements the gait pattern. 121
Within each mode, some variables of the robotic platform are updated along the 122 treatment sessions: PBWS, gait velocity and the percentage of the total range of 123 motion (ROM) [9] . The possibility of varying these parameters enables the 124 customization of the therapy to the progression of each patient and gives a higher 125 versatility for the treatment design. Additionally, the robotic platform also includes 126 a biofeedback strategy to motivate the children to actively correct their posture 127 during walking [7, 9] . The CPWalker robotic platform may be easily controlled by a 128 clinician through an intuitive interface, which controls and monitors the exercises in 129 real time. 130
Robotic training program 135
In order to define the objectives of the robot-based treatment, the authors adopted the 136 conceptual framework of ICF-CY [13] . The proposal was focused on improving the 137 principal gait-related functions derived from this international classification. Concretely, 138 the selected goals of the ICF-CY to be achieved with the treatment and the work 139 methodology implemented in the robotic device (in this case CPWalker), are presented 140
in Table 1 . 141 Table 1 . Goal settings of the ICF-CY and the robot-based solutions adopted with CPWalker platform
142
ICF-CY functional domain
[13]
Implementation on CPWalker
Mobility and stability of joint functions (b710, b715)
The different control modes of the exoskeleton are used to guide the movement of a single or multiple joints, improving motor control. The exoskeleton also helps to maintain stability through the coordinated actions of surrounding tissues. This domain is exercised along the whole treatment with diverse robotic assistance.
Muscle power functions (b730)
The second phase of the training requires the patient to contract a muscle or muscle groups to generate the necessary force in order to start and maintain the movement with AAN strategies. The force must be maintained for a time in the extremes of the gait pattern (maximum flexion and extension) in order to reach the these maximum values in the complete range of motion.
Muscle endurance functions (b740)
Muscle endurance is exercised when the patient is requested to sustain a muscle contraction to finalize the required movement with AAN strategies, mainly in the extremes of the gait pattern (maximum flexion and extension).
Control of voluntary movement functions (b760)
The voluntary movement is implemented through the control and coordination of simple and complex movements to collaborate with AAN strategies. Lower impedance implies more patient's control.
Gait pattern functions (b770)
Motor control and gait pattern functions are trained through the different control modes to guide the lower limbs following prescribed gait patterns at several velocities and supports.
Maintaining a body position (d415)
A biofeedback strategy for postural control is used to notify the patients when they lose the correct position of the upper body. See section "Postural control".
Walking (d450) Over-ground walking training is executed in all sessions with controlled PBWS, at different velocities and supports.
Proprioceptive functions (b260)
During random moments of the first training session, the patients perceive feeling using a mask on the eyes at the same time than the robot performs the movement for single or multiple joints with 100% of PBWS. 
143
To achieve the goals presented in Table 1 , authors previously performed a systematic 144 selection of variables based on the requirements of the National Strength and 145
Conditioning Association (NSCA) youth training guidelines, which suggests that 146 eccentric and explosive strength exercises should be the beginning of a proper training 147 to ensure greater muscle power generation and the transference of gains to gait (Table  148 2). 149 where the ROM, PBWS and gait velocity were the principal parameters under variation. 154
The intention was that the patient maximized the gains acquired in the whole 155 rehabilitation period (ideally the sum of robot-based exercises and common non-robotic 156 therapy). A detailed description of each phase follows:
i)
First phase: the main aim of this phase was to improve motor control, 158 teaching the patients the correct sequence of motion and increasing strength. which is in relation to the requisites exposed in Table 2 . Furthermore, PBWS declined 239 up to 30% of weight supported by the platform (Figure 4 With the aim of enhancing the patient's participation in the second phase and 252 consequently improving outcomes of the treatment, in sessions 9 to 16, position control was substituted by six adapted levels of impedance control in the joints of the 254 exoskeleton (Table 3) . 255
One of the main advantages of CPWalker robot was the possibility of selecting three 256 different modes of assistance individualized per joint beyond a pure position control 257 (high, medium and low impedances). In consonance with this, six situations (levels) 258 were adopted following the criteria of our clinical partners in order to define the scales 259 of difficulty in the assistance of knees and hips in the second phase (Table 3) . Thereby, 260 the patients were considered fit to move to the next level when they achieved a 261 performance higher than 85% in the execution of each session, together with its 262 corresponding parameters (ROM, PBWS and gait velocity) represented by Figure 4 . 263
This percentage of performance was calculated comparing the real motion executed by 264 the children and the desired gait pattern of each session. 265 Table 3 . Levels of assistance in first and second training phases: Position (P); High Impedance (HI); Medium 266 Impedance (MI); Low Impedance (LI). The assistance on knee joint always went behind the assistance on hip, 267 due to the knee movement during gait is performed following inertial forces, assigning to the hip movement The patient's motivation was subjectively measured in each session through a scale from 296 0 to 10 points, with 0 being no motivation and 10 being maximum motivation. 297
Metrics 298
In order to objectively measure the patient's evolution and due to the lack of 299 homogeneity among children with CP, authors decided to evaluate the progression of the therapy by comparing each patient to himself, instead of maintaining a control 301 group. We carried out some analyzes and evaluation metrics in different occasions of 302 the study (Table 4) : during the use of the robot, before the treatment begins (pre), in the 303 middle and after the whole sessions (post). 304 Bioengineering, Italy). In order to obtain gait kinetics, a set of reflective markers were 318 placed over the skin on discrete anatomical sites according to the Helen Hayes Model 319
[30]. Subjects walked barefoot at a self-selected speed. 320
Maximum isometric strength was measured in kgf with a hand-held dynamometer 321 microFET2 (Hoggan Scientific LLC, USA). Three records were taken and averaged for 322 each movement bilaterally (dorsiflexion, plantarflexion, knee flexion-extension, hip 323 flexion-extension, abduction and adduction). 324
The particularity of the SCALE assessment [26] was that it was evaluated by the same 325 physiotherapist bilaterally on three occasions (pre, middle and post), with the aim of 326 reducing the subjective error. 327
The changes of GMFM-88 [27] were collected for the 88 items, but the comparison 328 analyzes were implemented only for dimensions D (standing) and E (walking). 329
The kinesiophobia assessment consisted of a test composed of 10 questions of 1 to 4 330 points each. The responses were given by the patients without parents influence. 331
Two FAQ questionnaires were requested: one as initial questionnaire at the beginning 332 and the other as follow up at the end of the treatment. These surveys presented several 333 questions for parents and others referred to children. 334
During the whole treatment, ROM performance and force interactions were measured 335 for each session in order to evaluate if the patient was prepared to jump to the next stage 336 with more difficult parameters and level of assistance. 337
Finally, the users' motivation was subjectively evaluated by the practitioner from 0 to 10 338 points for each session with the robot. 339
Patients 340 Four children diagnosed with spastic CP affecting muscle strength and motor control of 341 lower limbs (two male, two female, weight 44.75±6.29 kg, height 1.56±0.29 m and age 342 14.50±2.38 years-old) were selected to be participants for testing the robotic training 343 proposal (P1, P2, P3 and P4 in Table 5 ). The inclusion criteria for patients' recruitment Table 3 , which were tailored for each patient between 371 sessions 9 to 16 (power training with AAN strategies), are represented in Figure 5,  372 where the maximum reached level was level 5 by P1 in the last two sessions. 373 
377
The level for P4 in S11 is not represented because P4 lost this session. scale of 36.60% for P1, 1.87% for P2, 20.81% for P3 and 16.23% for P4 ( Figure 6 a) . 382
378
Gait speed, endurance and global responses
The SCALE assessment also showed better results at the end of the robot-based 383 treatment (Figure 6 b) , [26] . In this case, although the value for the left leg in P1 was 384 kept same as at the beginning (Figure 6 b, red bars for P1), the rest of measures were 385 increased or maintained as maximum (SCALE equal to 10 points). 386
Finally, both the walked distance in the 6mwt and the walking speed in the 10mwt 387 increased after the training period ( Figure 6 c and d respectively) . The two situations 388 evaluated for the 10mwt are represented: a comfortable speed for each child (blue bars 389 in Figure 6 d) and the same exercise at maximum speed (orange bars in Figure 6 d) . 390
More concretely, the percentage of progressions comparing post and pre-analysis in 391 these metrics, were: P1 (6mwt: 26.92%; 10mwtcomf: 94.69%; 10mwtmax: 51.84%); P2 392 (6mwt: 14.86%; 10mwtcomf: 21.85%; 10mwtmax: 5.18%); P3 (6mwt: 75.68%; 10mwtcomf: 
403
Strength progression 404
In order to quantify the patient's maximum strength performing on defined and 405 individual movements without the robot, three measures were taken for each required 406 motion. According to that, Figure 7 
419
Kinematics and spatiotemporal variability 420
The 3D kinematic analysis provided outcomes focused on gait improvements respect to 421 normality. The GPS and GDI (Figure 8 ) are accepted indexes that represent how close the patient's gait is to the desired gait. Related to these metrics and comparing pre and 423 post analyzes, all the patients obtained better values for both sides (left and right) after 424 the robot-based treatment. Nevertheless, they were not clinically significant, except for 425 the right side of P1 (around 10 points in GDI). It is important to highlight that we 426 believe that the post results in P4 could be affected by personal circumstances non-427 related to the study that occurred the day of the test. 428 Table 6 shows the values of Figure 8 in detail and also includes some of the spatial-434 temporal parameters recorded during the studies. The average improvement percentages 435 (four patients) in spatiotemporal parameters were: 21.46±33.79% for mean velocity, 436 2.84±13.96% for cadence and 17.95±20.45% for step length. 437
[ Table 6 around 
Qualitative variables 452
The motivation was subjectively evaluated by the practitioner who was with the 453 children during the whole period of the study. The averaged motivation values on a 454 scale from 0 to 10 points were: 9.4 for P1, 8.6 for P2, 9.44 for P3 and 8.87 for P4. 455
Moreover, three of four patients decreased the kinesiophobia score after the 16 sessions. 456
Parents and patients filled a FAQ questionnaire at the beginning and a follow-up at the 457 end of the treatment. Regarding parent questionnaires, results show that all of them 458 thought that the strength and mobility were better at the end of the study thanks to the 459 robot-based therapy. Meanwhile half of them also included the endurance as an 460 improved variable due to the robot. 100% of parents felt satisfied towards the results of 461 robotic therapy with CPWalker, and they ensured that they would like to do it again. 462
The patients' opinion was very similar. They were also satisfied and, in general, they 463 described the treatment as: "really fun", "the robot makes you feel light and 464 independent" and "safe". 465
Discussion and Conclusion
466
The main aim of this research was to provide a first approach to the implementation of a 467 novel and defined robotic rehabilitation method that could cover the most important 468 clinical aspects of the ICF-CY framework. This proposal was tested with four pediatric 469 patients with CP, which provided us some preliminary outcomes to assess it. Although 470 the patients' progression was evaluated without a control group, we do not consider it as 471 a relevant limitation of the study, since the wide variety of differences among each child 472 with CP makes interesting and even necessary to expose the improvements by 473 comparing each patient with himself. 474
According to the results, the greatest benefits due to the robot-based treatment 475 corresponded to P1 and P3, who were the most affected levels of GMFCS (III in both 476 cases). In general, the higher values of gait speed and improved values of global 477 responses achieved by all the children in several tests, may be in benefit of the patients' 478 social mobility. Visual inspection of the graphics show that changes appeared after a 479 small number of sessions (middle tests) and they were commonly increased or 480 maintained until the post studies. 481
The most challenging part was the second phase of the training, which allowed the 482 possibility of adapting the level of assistance depending on the patient's progression. 483
Thereby, any subject could achieve the last level (level 6), and although the action of 484 reaching level 4 took P3 longer than the rest of children, this patient could pass through 485 it in the last three sessions. 486
It is interesting to highlight that the outcomes from isometric strength measure showed 487 important peaks of improvement, especially for hip and knee flexion-extension, which 488 was targeted with the CPWalker robotic platform. These higher values were observed 489 from the middle to the post analysis. The results of the present study are difficult to 490 compare with the scientific literature due to the lack of studies using exoskeletons for 491 gait resistance training. However, we can establish that our results are in line with 492 previous studies assessing conventional resistance strength training in CP [31] . 493
In relation to 3D-kinematic analysis, as we said before, P4 suffered a non-grata personal 494 of the PCI in all patients, which means that better gait performance implies lower 500 energy cost. 501
Finally, the motivation scale for the patients and the parents' satisfaction with the robot-502 based treatment was very high in most aspects. 503
The greatest achievements of this proposal come from the possibility of exercising 504 different gait functions in an orderly way, individualized per joint and at the same time 505 than over-ground walking. The proposed protocol could be applied to any current 506 robotic device for gait rehabilitation making minimal changes on it: e.g. in treadmill 507 pediatric platforms as Lokomat [14] , despite the impossibility of over-ground walking, 508 it already has different controllers, whose operation modes are close to the levels of 509 impedance of CPWalker, ensuring the progression of the therapy into the sessions. 510
Regarding working postural control in parallel with lower limbs training, which we 511 considered one of the key factors of the study, it may be solved through other solutions 512 if the selected robotic device does not have a similar strategy as described with 513
CPWalker, but it is crucial to guarantee its compliance to get the best results of the 514 treatment [12] . 515
The principal limitation of this research is that we followed up only in short term, so 516 further research with a higher population size is needed to evaluate if the improvements 517 will be kept over time. Moreover, although other studies propose interventions on 3 518 non-consecutive days per week [31], the patients of the present study performed the 519 robotic exercises during 2 non-consecutive sessions per week. This enabled them to 520 continue their conventional therapies in parallel to the robot-based rehabilitation. The 521 conventional therapies had been attended on a regular basis for years, so authors 522 considered to not abolish them for ethical reasons. The conventional therapies of the 523 patients were performed 2 days a week and consisted of exercises on balance and strength focusing on quadriceps and abs. Although the patients were doing conventional 525 and robotic therapy in parallel, authors consider that the improvements achieved in this 526 proposal are exclusively associated to the use of the CPWalker, since the patients got 527 non-robotic therapies for years with no significant improvements. In conclusion, the 528 method implemented with CPWalker is complementary to the common therapies, 529
providing new possibilities to the clinical practice through robotic rehabilitation and 530 also reaching better outcomes than conventional therapy alone. 531
We are currently working on new future lines in which we plan to include 532 electromyography during the use of the robotic trainer in order to assess more 533 objectively the patients' progressions. Electromyography data will serve to evaluate the 534 therapy outcomes in terms of reorganization of the neural structures, which will be 535 performed by analyzing the raw neural drive to muscles and the muscle synergies. 536
In a nutshell, this manuscript contributed with a defined robotic treatment that could be 537 implemented in most of the existing rehabilitation robotic devices for lower limbs, and 538 which we evaluated positively in four patients with CP using CPWalker. 539
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